AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20601163
Drug: Feedback intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Feedback intervention - patients complete monthly symptom surveys, and severity of symptoms is mailed to the renal provider with treatment options.
Trial: 20601163
Drug: Management intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Management intervention - patients complete monthly symptom surveys and are evaluated by a symptom management nurse who provides recommendations for treatment.
Trial: 15861085
Drug: Tumescent lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tumescent lidocaine injection into the neck (lidocaine 0.1%, NaHCO3 12.5 mEq/L, epinephrine 1:1,000,000, 7 mg/kg)
Trial: 15861085
Drug: Tumescent lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tumescent lidocaine injection into the thighs (lidocaine 0.1%, NaHCO3 12.5 mEq/L, epinephrine 1:1,000,000, 7 mg/kg)
Trial: 15861085
Drug: Tumescent lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tumescent lidocaine injection into the neck
Trial: 15861085
Drug: Tumescent lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tumescent lidocaine injection into the thighs
Trial: 10378864
Drug: IFNbeta‐1a (Avonex)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNbeta‐1a (Avonex) treatment for 104 weeks
Trial: 10378864
Drug: IFNbeta‐1a (Avonex)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNbeta‐1a (Avonex) treatment
Trial: 1658942
Drug: Logiparin 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Logiparin 50 mg/kg body weight once daily for 7 days, starting 2 hours preoperatively.
Trial: 1658942
Drug: Placebo once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo once daily for 7 days, starting 2 hours preoperatively.
Trial: 30328725
Drug: Preservative-free tafluprost/timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-free tafluprost/timolol fixed combination (TTFC) administered in the evening (20:00) for 3 months
Trial: 30328725
Drug: Preservative-free tafluprost/timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-free tafluprost/timolol fixed combination (TTFC) administered in the morning (08:00) for 3 months
Trial: 30328725
Drug: Preserved latanoprost
RxNorm normalized name: Latanoprost
DrugBank: Latanoprost (DB00654)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Preserved latanoprost monotherapy
Trial: 26383099
Drug: Insect therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insect therapy (5 crickets in a cage with sufficient fodder and a detailed instruction manual)
Trial: 26383099
Drug: Insect therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insect therapy
Trial: 24899596
Drug: Omega-3 PUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 PUFA supplementation (2710 mg EPA/day and 2040 mg DHA/day for one month)
Trial: 22329674
Drug: pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pantoprazole 40 mg daily
Trial: 20398020
Drug: Low-dose prednisone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisone comedication
Trial: 20398020
Drug: Non-low-dose prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-low-dose prednisone (control group)
Trial: 17993770
Drug: 5 h
RxNorm normalized name: B-75 High Potency
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 h i.v. infusion of active ghrelin
Trial: 25778837
Drug: Parental trait
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parental trait anxiety pre- and post-treatment
Trial: 11580151
Drug: Interferon continued
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon continued for 1 more year with gradual reduction of the dose
Trial: 9578788
Drug: DTPw-HB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPw-HB vaccine booster dose at 18 months of age
Trial: 3475196
Drug: Cefotiam in
RxNorm normalized name: cefotiam
DrugBank: Cefotiam (DB00229)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefotiam in 2 doses of 2 g for 5 days
Trial: 3475196
Drug: Cefotiam in
RxNorm normalized name: cefotiam
DrugBank: Cefotiam (DB00229)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefotiam in 2 doses of 2 g only perioperatively
Trial: 3475196
Drug: Ceftriaxone in
RxNorm normalized name: ceftriaxone Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone in a single dose of 2 g preoperatively
Trial: 3475196
Drug: Low-dose prophylaxis
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prophylaxis with 1 g ceftriaxone preoperatively
Trial: 25848848
Drug: 550 mg
RxNorm normalized name: xylitol 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 550 mg NSAID + paracervical block (group 2)
Trial: 25848848
Drug: 550 mg
RxNorm normalized name: xylitol 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 550 mg NSAID + paracervical analgesic cream (group 3)
Trial: 25848848
Drug: 550 mg
RxNorm normalized name: xylitol 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 550 mg NSAID (group 1)
Trial: 25848848
Drug: 550 mg
RxNorm normalized name: xylitol 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 550 mg NSAID + intrauterine analgesic instillation (group 4)
Trial: 21282434
Drug: Conventional dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dose of sulfadoxine-pyrimethamine (25/1.25 mg/kg of body weight)
Trial: 21282434
Drug: Double dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double dose of sulfadoxine-pyrimethamine (50/2.5 mg/kg of body weight)
Trial: 2973693
Drug: Heat-treated recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat-treated recombinant DNA hepatitis B vaccine
Trial: 2973693
Drug: Vaccine stored
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine stored at 4 degrees C
Trial: 29675875
Drug: Supportive care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive care bundle (modulation of the infants' states, non‐nutritive sucking, facilitated tucking, and oral sucrose feeding)
Trial: 20697092
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with single-agent rituximab followed by 4 cycles of maintenance therapy every 2 months (prolonged exposure)
Trial: 20697092
Drug: Observation (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observation (no further treatment after induction)
Trial: 17015058
Drug: d-methamphetamine (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-methamphetamine (0.25 mg/kg)
Trial: 17015058
Drug: d-methamphetamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-methamphetamine (0.5 mg/kg)
Trial: 17015058
Drug: racemic methamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: racemic methamphetamine (0.5 mg/kg)
Trial: 17015058
Drug: l-methamphetamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-methamphetamine (0.5 mg/kg)
Trial: 17015058
Drug: l-methamphetamine (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-methamphetamine (0.25 mg/kg)
Trial: 14551525
Drug: Early statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early statin therapy started before discharge from hospital after an acute coronary syndrome
Trial: 2491867
Drug: Intravenous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous recombinant tissue-type plasminogen activator (rt-PA) 100 mg
Trial: 2491867
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase 1.5 million units
Trial: 184771
Drug: Topical corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroid therapy (dexamethasone)
Trial: 184771
Drug: Steroid-antibiotic preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-antibiotic preparation
Trial: 184771
Drug: Corticosteroids (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids (various formulations)
Trial: 21148045
Drug: Oral bosutinib
RxNorm normalized name: Bosutinib
DrugBank: Bosutinib (DB06616)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral bosutinib 100 mg alone
Trial: 21148045
Drug: Oral bosutinib
RxNorm normalized name: Bosutinib
DrugBank: Bosutinib (DB06616)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral bosutinib 100 mg with ketoconazole 400 mg
Trial: 17679042
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil 40 mg (second study)
Trial: 17679042
Drug: Valsartan 320
RxNorm normalized name: valsartan 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 320 mg (second study)
Trial: 17679042
Drug: Irbesartan 300
RxNorm normalized name: irbesartan 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 300 mg (second study)
Trial: 17679042
Drug: Valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 160 mg (second study)
Trial: 9884850
Drug: Single-dose spinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose spinal anaesthesia (2.5 mL of bupivacaine 0.5% plain)
Trial: 778366
Drug: Combined ampicillin
RxNorm normalized name: Ampicillin
DrugBank: Ampicillin (DB00415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined ampicillin and gentamicin therapy with intrathecal administration of gentamicin
Trial: 778366
Drug: Combined ampicillin
RxNorm normalized name: Ampicillin
DrugBank: Ampicillin (DB00415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined ampicillin and gentamicin therapy without intrathecal administration of gentamicin
Trial: 30636504
Drug: Methylnaltrexone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylnaltrexone (8 or 12 mg according to weight)
Trial: 26000677
Drug: Kiva VCF
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kiva VCF Treatment System
Trial: 7737135
Drug: Cyclophosphamide (CP)
DrugBank: Cyclophosphamide (DB00531)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cyclophosphamide (CP) treatment (50-200 mg/day)
Trial: 7737135
Drug: Cyclophosphamide (CP)
DrugBank: Cyclophosphamide (DB00531)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cyclophosphamide (CP) treatment (high doses)
Trial: 7737135
Drug: Patients without
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients without chemotherapy (n=5)
Trial: 2407003
Drug: Prednisone (PRED)
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone (PRED) therapy
Trial: 2407003
Drug: No Prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No Prednisone (NOPRED) therapy
Trial: 34415
Drug: Chlorpheniramine (H1-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine (H1-receptor blocker)
Trial: 34415
Drug: Cimetidine (H2-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (H2-receptor blocker)
Trial: 34415
Drug: Chlorpheniramine and
RxNorm normalized name: Chlorpheniramine and epinephrine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine and Cimetidine (both intravenous)
Trial: 31298350
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human basic fibroblast growth factor combined with compound polymyxin B ointment and local application of insulin
Trial: 31298350
Drug: Compound polymyxin
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound polymyxin B ointment
Trial: 25849681
Drug: Nitroglycerine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerine infusion (NTG group)
Trial: 17427617
Drug: Combination product
RxNorm normalized name: Drug-device combination product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination product of peppermint oil and caraway oil
Trial: 17427617
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of peppermint oil
Trial: 17427617
Drug: Commonly recommended
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commonly recommended dosage of peppermint oil
Trial: 11747323
Drug: Raloxifene 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 600 mg daily
Trial: 9010041
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg ibandronate
Trial: 15251160
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg ibandronate
Trial: 8343314
Drug: Previous aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Previous aspirin use
Trial: 30894560
Drug: 40 g high
RxNorm normalized name: HIGH DENSITY POLYETHYLENE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g high amylose RS2
Trial: 19329015
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion of 0.125% bupivacaine with 20 microg/kg/hr midazolam (Group BM)
Trial: 19329015
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion of 0.125% bupivacaine alone (Group B)
Trial: 9689267
Drug: Dexamethasone 0.17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.17 mg/kg i.v.
Trial: 9689267
Drug: Droperidol 0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 0.02 mg/kg i.v.
Trial: 1198232
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (PGE2) tablets
Trial: 1198232
Drug: Intravenous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous oxytocin after amniotomy
Trial: 23221898
Drug: Electroconvulsive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive therapy (ECT) with sodium valproate
Trial: 23221898
Drug: Electroconvulsive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive therapy (ECT) without sodium valproate
Trial: 10815116
Drug: Imipramine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (up to 300 mg/d)
Trial: 8839505
Drug: High-fruit and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fruit and -vegetable diets (approximately 16 mg/d carotenoids)
Trial: 8839505
Drug: High-carotenoid diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-carotenoid diet with additional broccoli (205 g/d) for 5 days
Trial: 1530752
Drug: Deep anesthesia
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep anesthesia with high doses of sufentanil
Trial: 1530752
Drug: Lighter anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lighter anesthesia with halothane and morphine
Trial: 6331157
Drug: Enalapril (MK-421,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (MK-421, 10 to 20 mg bid)
Trial: 6331157
Drug: Hydrochlorothiazide (HCTZ,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ, 25 to 50 mg bid)
Trial: 6331157
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (MK-421 + HCTZ)
Trial: 25945019
Drug: 14 d
RxNorm normalized name: PEG-14 dimethicone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14 d moxifloxacin‐based sequential therapy (MOX‐ST group)
Trial: 25945019
Drug: 14 d
RxNorm normalized name: PEG-14 dimethicone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14 d clarithromycin‐based sequential therapy (CLA‐ST group)
Trial: 17075320
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy (29 patients)
Trial: 10848740
Drug: Calcipotriol ointment
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol ointment (50 microg g‐1) applied immediately before irradiation
Trial: 10848740
Drug: Calcipotriol cream
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol cream (50 microg g‐1) applied immediately before irradiation
Trial: 1563426
Drug: Diluted iodine
RxNorm normalized name: Iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diluted iodine solution or barium suspension
Trial: 27663358
Drug: Standard opioid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard opioid prescription
Trial: 22589423
Drug: 42 mg
RxNorm normalized name: lithium 42 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 42 mg transdermal nicotine
Trial: 6489697
Drug: HCl control
RxNorm normalized name: DIETHYLPROPION HYDROCHLORIDE 75 mg ORAL TABLET [Diethylpropion HCl Controlled-Release]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCl control solution (200 ml of 100 mM HCl)
Trial: 29972001
Drug: RT and
RxNorm normalized name: Comfort and Ease KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT and intradermal needling (group A)
Trial: 22682750
Drug: 4 months
RxNorm normalized name: leuprolide 30 mg/4 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 months of neo-adjuvant androgen deprivation (NAD) before radiation therapy (RT)
Trial: 22682750
Drug: 8 months
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 months of neo-adjuvant androgen deprivation (NAD) before radiation therapy (RT)
Trial: 22682750
Drug: Neo-adjuvant androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neo-adjuvant androgen deprivation (NAD) in addition to radiation therapy
Trial: 16048922
Drug: Rifampin orally
RxNorm normalized name: Rifampin
DrugBank: Rifampin (DB01045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin orally at 10 mg/kg of body weight and streptomycin intramuscularly at 15 mg/kg of body weight daily for 2 weeks
Trial: 3072420
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg captopril once daily
Trial: 3072420
Drug: 37.5 mg
RxNorm normalized name: pemoline 37.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 37.5 mg captopril twice daily
Trial: 3072420
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg captopril three times daily
Trial: 21354935
Drug: Pelvic methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Pelvic methotrexate (MTX) injection via the posterior fornix + mifepristone + traditional Chinese medicine
Trial: 21354935
Drug: Intramuscular MTX
RxNorm normalized name: MTX
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular MTX injection + mifepristone + traditional Chinese medicine
Trial: 21354935
Drug: Mifepristone +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone + traditional Chinese medicine
Trial: 19365399
Drug: escitalopram (serotonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: escitalopram (serotonin reuptake inhibitor)
Trial: 19365399
Drug: nortriptyline (norepinephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nortriptyline (norepinephrine reuptake inhibitor)
Trial: 17455472
Drug: Shenfu injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu injection (SF)
Trial: 9757602
Drug: High-salt diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-salt diet (21.0 g NaCl)
Trial: 9757602
Drug: Normal-salt diet
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Normal-salt diet (approximately 5.6 g NaCl)
Trial: 7831452
Drug: Novel nonsedating
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Novel nonsedating compound (dose not specified)
Trial: 3242576
Drug: Antihypertensive drugs
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drugs (ACE inhibitors, calcium antagonists, direct vasodilators, alpha‐adrenoceptor blocker, beta‐adrenoceptor blocker)
Trial: 3242576
Drug: Antihypertensive agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive agents (four types)
Trial: 30263038
Drug: Green cardamom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green cardamom (GC) - 2 capsules of 500 mg three times per day for 3 months
Trial: 15590252
Drug: Alfentanil (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (1 mg)